All In Biotech

Drug Trial Radar · NCT03796676

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF-04965842 CO-ADMINISTERED WITH BACKGROUND MEDICATED TOPICAL THERAPY IN ADOLESCENT PARTICIPANTS 12 TO <18 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Last checked: Nov 19, 2026Latest source record: Apr 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 287 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

287

Actual

Start

Feb 18, 2019

Primary completion

Apr 8, 2020

Study completion Apr 8, 2020

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jan 8, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double blind, placebo controlled, parallel group, Phase 3 study to evaluate the efficacy and safety of PF 04965842 in adolescent participants 12 to \<18 years of age with moderate to severe AD.

Conditions

  • Atopic Dermatitis

Interventions

  • PlaceboDrug

    Placebo

  • PF-04965842Drug

    100 mg QD

  • PF04965842Drug

    200 mg QD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Investigator's Global Assessment (IGA) Response of 'Clear' (0) or 'Almost Clear' (1) and ≥2 Points Improvement From Baseline at Week 12Time frame: Baseline to Week 12
  2. Percentage of Participants Achieving Eczema Area and Severity Index (EASI) Response ≥ 75% Improvement From Baseline at Week 12Time frame: Baseline to Week 12

Locations

136 sites in 14 countries. Site status is shown where the registry gives one.

  • Clinical Research Center of Alabama, LLC

    Birmingham, Alabama

  • Madera Family Medical Group

    Madera, California

  • Allergy & Asthma Associates of Southern California dba Southern California Research

    Mission Viejo, California

  • UC Davis

    Sacramento, California

  • Moonshine Research Center, Inc.

    Doral, Florida

  • Homestead Research Institute

    Homestead, Florida

  • Olympian Clinical Research

    Largo, Florida

  • Clinical Trials Solutions

    Miami, Florida

  • Global Health Clinical Trials Corp

    Miami, Florida

  • La Salud Research Clinic, Inc.

    Miami, Florida

  • Nicklaus Children's Hospital

    Miami, Florida

  • South Miami Medical & Research Group, Inc.

    Miami, Florida

  • Ciocca Dermatology, PA

    Miami, Florida

  • INTERMED Medical Research Center, Inc

    Miami, Florida

  • Suncoast Research Associates

    Miami, Florida

  • AdventHealth Orlando

    Orlando, Florida

  • AdventHealth Pediatric Dermatology Orlando

    Orlando, Florida

  • AdventHealth Orlando - Investigational Drug Services

    Orlando, Florida

  • Outpatient Service Center-AdventHealth Orlando

    Orlando, Florida

  • Pediatric Outpatient Procedures and Sedation

    Orlando, Florida

  • NeuroSkeletal Imaging

    Orlando, Florida

  • Accel Research Sites - Pure Skin Dermatology & Aesthetics

    Orlando, Florida

  • Accel Research Sites - Nona Pediatric Center

    Orlando, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Columbus Regional Research Institute

    Columbus, Georgia

  • Meridian Clinical Research, LLC

    Savannah, Georgia

  • Midwest Allergy Sinus Asthma, SC

    Normal, Illinois

  • NorthShore University HealthSystem Dermatology Clinical Trials Unit

    Skokie, Illinois

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana

  • The South Bend Clinic Center for Research

    South Bend, Indiana

  • Forefront Dermatology S.C.

    Louisville, Kentucky

  • Institute for Asthma and Allergy

    Chevy Chase, Maryland

  • DermAssociates, LLC

    Rockville, Maryland

  • Chesapeake Clinical Research, Inc.

    White Marsh, Maryland

  • Clarkston Skin Research

    Clarkston, Michigan

  • Wayne State University / Integrative Biosciences Center

    Detroit, Michigan

  • Center for Outpatient Health

    St Louis, Missouri

  • St. Louis Children's Hospital

    St Louis, Missouri

  • St. Louis Children's Hospital

    St Louis, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

Showing 40 of 136 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.